RojymonJacobMDFRCR, DABR, MBA
Radiation Oncology • Jackson, MSProfessor and Chairman, Department of Radiation Oncology, University of Mississippi Medical Center
Dr. Jacob is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 N State Street
Jackson, MS 39216Phone+1 601-815-6886
Summary
- Dr. Rojymon Jacob is a Radiation Oncology specialist, tenured Professor and current Chairman at the UMMC Department of Radiation Oncology. He was fellowship-trained at Temple University Hospital/Fox Chase Cancer Center and also holds an MBA from the University of Alabama at Birmingham. He has extensive experience in various areas such as brachytherapy, oncology, stereotactic and functional surgery, with focused expertise in treating gastro-intestinal malignancies. He has numerous publications in influential medical journals, including the Journal of Gastrointestinal Oncology and the Journal of the National Comprehensive Cancer Network. His contributions to clinical trials have focused on areas including Stereotactic Body Radiotherapy, Trans Arterial Chemoembolization, and hypo-fractionated radiation to treat rectal cancers.
Education & Training
University of Alabama at BirminghamMBA, 2012 - 2014
Temple University Hospital/Fox Chase Cancer CenterFellowship, Radiation Oncology, 2002 - 2004- Royal Marsden HospitalFRCR, 1996 - 1999
University of Kerala Medical CollegeClass of 1990, MBBS, MD
Certifications & Licensure
CA State Medical License 2006 - 2026
MS State Medical License 2024 - 2025
AL State Medical License 2006 - 2024
GA State Medical License 2011 - 2023
PA State Medical License 2002 - 2004- American Board of Radiology Radiation Oncology
- Royal College of Radiologists- UKFRCR
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma Start of enrollment: 2010 Oct 01
- Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002) Start of enrollment: 2010 Oct 01
- Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 48 citationsNCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.Al B Benson, Michael I D'Angelica, Thomas Abrams, Daniel E Abbott, Aijaz Ahmed
Journal of the National Comprehensive Cancer Network. 2023-07-01 - 477 citationsHepatobiliary cancers, Version 2.2021Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert A. Anders
Journal of the National Comprehensive Cancer Network. 2021-05-01 - 18 citationsSubcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer.Andrew M. McDonald, John B. Fiveash, Robert S. Kirkland, Rex A. Cardan, Rojymon Jacob
Urologic Oncology. 2017-11-01
Press Mentions
A One-Stop Shop for Colorectal Cancer CareMarch 1st, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
